Company · CIK 0001100412 · SIC 2834 — Pharmaceutical Preparations
ARRAY BIOPHARMA INC · ARRY
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2017 SForm 4 → | Sep 29, 6:22 pm EDT | Kyle LefkoffDirector | 38,865 | $12.31 | $478,428 | 12,720 | −75.3% | plan? |
| Sep 29, 2017 MForm 4 → | Sep 29, 6:22 pm EDT | Kyle LefkoffDirector | 45,000 | $10.58 | $476,100 | 51,585 | — | plan? |
| Aug 14, 2017 MForm 4 → | Aug 15, 4:31 pm EDT | Jason HaddockCFO | 20,000 | $3.77 | $75,400 | 20,000 | — | plan? |
| Apr 1, 2017 FForm 4/A → | Apr 6, 8:32 pm EDT | Ron SquarerCEO, Director | 17,563 | $8.94 | $157,013 | 115,683 | — | plan? |
| Apr 1, 2017 FForm 4/A → | Apr 6, 8:32 pm EDT | Victor SandorChief Medical Officer | 7,303 | $8.94 | $65,289 | 170,125 | — | plan? |
| Apr 1, 2017 FForm 4/A → | Apr 6, 8:31 pm EDT | Nicholas A SaccomanoCSO | 6,543 | $8.94 | $58,494 | 37,851 | — | plan? |
| Apr 1, 2017 FForm 4/A → | Apr 6, 8:31 pm EDT | Andrew R RobbinsCOO | 9,167 | $8.94 | $81,953 | 36,684 | — | plan? |
| Apr 1, 2017 FForm 4/A → | Apr 6, 8:30 pm EDT | John R MooreVP, General Counsel | 6,370 | $8.94 | $56,948 | 40,102 | — | plan? |
| Apr 1, 2017 FMForm 4 → | Apr 4, 9:43 pm EDT | Ron SquarerCEO, Director | 30,948 | $8.94 | $107,655 | 114,327 | — | plan? amended |
| Apr 1, 2017 FMForm 4 → | Apr 4, 9:43 pm EDT | Victor SandorChief Medical Officer | 12,834 | $8.94 | $44,897 | 172,406 | — | plan? amended |
| Apr 1, 2017 FMForm 4 → | Apr 4, 9:42 pm EDT | Nicholas A SaccomanoCSO | 11,410 | $8.94 | $40,543 | 37,526 | — | plan? amended |
| Apr 1, 2017 FMForm 4 → | Apr 4, 9:42 pm EDT | Andrew R RobbinsCOO | 16,136 | $8.94 | $56,259 | 39,558 | — | plan? amended |
| Apr 1, 2017 FMForm 4 → | Apr 4, 9:41 pm EDT | John R MooreVP, General Counsel | 11,126 | $8.94 | $39,408 | 42,064 | — | plan? amended |
| Mar 31, 2017 SForm 4 → | Apr 4, 9:41 pm EDT | Kyle LefkoffDirector | 45,000 | $8.92 | $401,400 | 6,585 | −87.2% | plan? amended |
| Mar 28, 2017 SForm 4 → | Mar 30, 5:23 pm EDT | Charles M BaumDirector | 25,000 | $9.27 | $231,750 | 5,000 | −83.3% | plan? |
| Mar 28, 2017 MForm 4 → | Mar 30, 5:23 pm EDT | Charles M BaumDirector | 25,000 | $3.87 | $96,750 | 30,000 | — | plan? |
| Nov 28, 2016 GForm 4/A → | Aug 17, 2018, 4:46 pm EDT | Kyle LefkoffDirector | 2,085 | — | — | 6,500 | — | plan? |
| Nov 28, 2016 GMForm 4 → | Apr 4, 2017, 9:41 pm EDT | Kyle LefkoffDirector | 47,000 | $3.99 | $179,450 | 51,585 | — | plan? late amended |
| Oct 29, 2016 MForm 4 → | Oct 31, 7:46 pm EDT | Gil J Van LunsenDirector | 5,000 | $5.83 | $29,150 | 10,260 | — | plan? |
| Oct 29, 2016 MForm 4 → | Oct 31, 7:15 pm EDT | John A OrwinDirector | 5,000 | $5.83 | $29,150 | 5,000 | — | plan? |
| Oct 29, 2016 MForm 4 → | Oct 31, 7:15 pm EDT | Kyle LefkoffDirector | 5,000 | $5.83 | $29,150 | 8,585 | — | plan? |
| Oct 29, 2016 MForm 4 → | Oct 31, 7:15 pm EDT | Gwen A. FyfeDirector | 5,000 | $5.83 | $29,150 | 5,000 | — | plan? |
| Oct 29, 2016 MForm 4 → | Oct 31, 7:15 pm EDT | Charles M BaumDirector | 5,000 | $5.83 | $29,150 | 5,000 | — | plan? |
| Sep 28, 2016 SForm 4 → | Sep 30, 3:55 pm EDT | Redmile Group, LLC +110% Owner | 2,492,578 | $6.36 | $15,852,796 | 16,658,072 | −13.0% | plan? |
| Sep 22, 2016 FMForm 4 → | Sep 23, 7:52 pm EDT | Victor SandorChief Medical Officer | 127,007 | $3.69 | $468,656 | 169,616 | — | plan? |
| Sep 14, 2016 PForm 4 → | Sep 16, 4:00 pm EDT | Redmile Group, LLC +110% Owner | 400,000 | $3.51 | $1,403,720 | 19,150,650 | +2.13% | plan? |
| Sep 14, 2016 SForm 4 → | Sep 16, 4:00 pm EDT | Redmile Group, LLC +110% Owner | 400,000 | $3.50 | $1,400,292 | 19,122,650 | −2.05% | plan? |
| Apr 1, 2016 FForm 4 → | Apr 5, 6:56 pm EDT | Ron SquarerCEO, Director | 5,878 | $3.00 | $17,634 | 107,463 | — | plan? |
| Apr 1, 2016 FForm 4 → | Apr 5, 6:56 pm EDT | Victor SandorChief Medical Officer | 2,651 | $3.00 | $7,953 | 104,843 | — | plan? |
| Apr 1, 2016 FForm 4 → | Apr 5, 6:55 pm EDT | Nicholas A SaccomanoCSO | 2,564 | $3.00 | $7,692 | 35,186 | — | plan? |
| Apr 1, 2016 FForm 4 → | Apr 5, 6:54 pm EDT | Andrews R RobbinsCOO | 3,367 | $3.00 | $10,101 | 36,008 | — | plan? |
| Apr 1, 2016 FForm 4 → | Apr 5, 6:54 pm EDT | John R MooreVP, General Counsel | 2,505 | $3.00 | $7,515 | 39,754 | — | plan? |
| Jan 20, 2016 PForm 4 → | Jan 22, 4:25 pm EST | Redmile Group, LLC +110% Owner | 300,000 | $3.19 | $957,000 | 19,150,650 | +1.59% | plan? |
| Jan 12, 2016 PForm 4 → | Jan 14, 4:14 pm EST | Redmile Group, LLC +110% Owner | 75,000 | $3.60 | $270,000 | 18,850,650 | +0.40% | plan? |
| Jan 7, 2016 PForm 4 → | Jan 11, 7:33 pm EST | Redmile Group, LLC +110% Owner | 925,000 | $3.67 | $3,394,500 | 18,775,650 | +5.18% | plan? |
| Sep 29, 2015 PForm 4/A → | Jan 11, 2016, 7:27 pm EST | Redmile Group, LLC +110% Owner | 600,140 | $4.58 | $2,750,700 | 17,850,650 | +3.48% | plan? |
| Sep 29, 2015 PForm 4 → | Oct 1, 7:15 pm EDT | Redmile Group, LLC +110% Owner | 782,592 | $4.58 | $3,582,681 | 18,033,102 | +4.54% | plan? amended |
| Sep 22, 2015 FMForm 4 → | Sep 24, 2:01 pm EDT | Victor SandorChief Medical Officer | 127,056 | $5.18 | $658,150 | 107,494 | — | plan? |
| Aug 26, 2015 PForm 4 → | Aug 28, 5:29 pm EDT | Redmile Group, LLC +110% Owner | 49,900 | $5.48 | $273,452 | 17,250,510 | +0.29% | plan? |
| Aug 21, 2015 PForm 4 → | Aug 25, 7:16 pm EDT | Redmile Group, LLC +110% Owner | 790,000 | $5.38 | $4,252,200 | 17,200,610 | +4.81% | plan? |
| Aug 11, 2015 PForm 4 → | Aug 13, 7:16 pm EDT | Redmile Group, LLC +110% Owner | 532,500 | $5.88 | $3,131,525 | 16,410,610 | +3.35% | plan? |
| Aug 6, 2015 PForm 4 → | Aug 10, 8:59 pm EDT | Redmile Group, LLC +110% Owner | 1,048,993 | $5.80 | $6,079,631 | 15,878,110 | +7.07% | plan? |
| May 8, 2015 SForm 4 → | May 12, 8:21 pm EDT | Charles M BaumDirector | 25,000 | $7.38 | $184,483 | 0 | −100% | plan? |
| May 8, 2015 MForm 4 → | May 12, 8:21 pm EDT | Charles M BaumDirector | 25,000 | $3.86 | $96,500 | 25,000 | — | plan? |
| Apr 1, 2015 AForm 4 → | Apr 3, 6:57 pm EDT | Nicholas A SaccomanoCSO | 27,500 | — | — | 35,800 | — | plan? |
| Apr 1, 2015 AForm 4 → | Apr 3, 6:56 pm EDT | John R MooreVP, General Counsel | 26,875 | — | — | 42,259 | — | plan? |
| Apr 1, 2015 AForm 4 → | Apr 3, 6:55 pm EDT | Victor SandorChief Medical Officer | 31,250 | — | — | 42,768 | — | plan? |
| Apr 1, 2015 AForm 4 → | Apr 3, 6:54 pm EDT | Andrews R RobbinsSVP, Commercial Operations | 39,375 | — | — | 39,375 | — | plan? |
| Apr 1, 2015 AForm 4 → | Apr 3, 6:51 pm EDT | Ron SquarerCEO, Director | 75,625 | — | — | 108,166 | — | plan? |
| Mar 3, 2015 SForm 4 → | Mar 4, 8:50 pm EST | Kyle LefkoffDirector | 70,000 | $8.00 | $560,070 | 3,585 | −95.1% | plan? |
| Mar 3, 2015 MForm 4 → | Mar 4, 8:50 pm EST | Kyle LefkoffDirector | 70,000 | $2.80 | $196,050 | 73,585 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 8:16 pm EST | Andrews R RobbinsSVP, Commercial Operations | 21,576 | $8.25 | $178,002 | 0 | −100% | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 8:13 pm EST | Ron SquarerCEO, Director | 40,000 | $8.25 | $330,000 | 12,927 | −75.6% | plan? amended |
| Mar 1, 2015 FMForm 4 → | Mar 4, 8:16 pm EST | Andrews R RobbinsSVP, Commercial Operations | 42,562 | $7.96 | $338,794 | 21,576 | — | plan? late |
| Mar 1, 2015 FMForm 4 → | Mar 4, 8:16 pm EST | Victor SandorChief Medical Officer. | 23,245 | $7.96 | $185,030 | 11,635 | — | plan? late |
| Mar 1, 2015 FMForm 4 → | Mar 4, 8:14 pm EST | John R MooreVP, General Counsel | 30,448 | $7.96 | $242,366 | 15,364 | — | plan? late amended |
| Mar 1, 2015 FMForm 4 → | Mar 4, 8:13 pm EST | Ron SquarerCEO, Director | 102,835 | $7.96 | $818,567 | 52,927 | — | plan? late amended |
| Mar 1, 2015 FMForm 4 → | Mar 4, 8:13 pm EST | Nicholas A SaccomanoCSO | 15,486 | $7.96 | $123,269 | 7,420 | — | plan? late |
| Mar 1, 2015 FMForm 4 → | Mar 4, 8:12 pm EST | David SnitmanCOO and VP, Business Devel. | 15,429 | $7.96 | $122,815 | 7,477 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2015 AForm 4 → | Apr 3, 6:55 pm EDT | Victor SandorChief Medical Officer | 187,500 | — | — | 187,500 | — | |
| Apr 1, 2015 AForm 4 → | Apr 3, 6:51 pm EDT | Ron SquarerCEO, Director | 453,750 | — | — | 453,750 | — | |
| Mar 3, 2015 MForm 4 → | Mar 4, 8:50 pm EST | Kyle LefkoffDirector | 70,000 | — | — | 0 | — | |
| Mar 2, 2015 AForm 4 → | Apr 3, 6:54 pm EDT | Andrews R RobbinsSVP, Commercial Operations | 286,250 | — | — | 236,250 | — | late |
| Mar 1, 2015 MForm 4/A → | Mar 24, 7:59 pm EDT | Ron SquarerCEO, Director | 77,881 | — | — | 77,881 | — | |
| Mar 1, 2015 MForm 4 → | Mar 4, 8:16 pm EST | Andrews R RobbinsSVP, Commercial Operations | 32,069 | — | — | 32,069 | — | late |
| Mar 1, 2015 MForm 4 → | Mar 4, 8:16 pm EST | Victor SandorChief Medical Officer. | 17,440 | — | — | 17,440 | — | late |
| Mar 1, 2015 MForm 4 → | Mar 4, 8:14 pm EST | John R MooreVP, General Counsel | 22,906 | — | — | 22,906 | — | late amended |
| Mar 1, 2015 MForm 4 → | Mar 4, 8:13 pm EST | Ron SquarerCEO, Director | 77,881 | — | — | 77,881 | — | late amended |
| Mar 1, 2015 MForm 4 → | Mar 4, 8:13 pm EST | Nicholas A SaccomanoCSO | 11,453 | — | — | 11,453 | — | late |
| Mar 1, 2015 MForm 4 → | Mar 4, 8:12 pm EST | David SnitmanCOO and VP, Business Devel. | 11,453 | — | — | 11,453 | — | late |